{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:58:31Z","timestamp":1770915511109,"version":"3.50.1"},"reference-count":26,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,2,7]]},"DOI":"10.18632\/oncotarget.14192","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T19:25:59Z","timestamp":1482866759000},"page":"9672-9685","source":"Crossref","is-referenced-by-count":17,"title":["Increased risk of poor survival in ovarian cancer patients with high expression of SNAI2 and lymphovascular space invasion"],"prefix":"10.18632","volume":"8","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufen","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics and Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,25]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","article-title":"Latest research and treatment of advanced-stage epithelial ovarian cancer","volume":"10","author":"Herzog","year":"2013","journal-title":"NAT REV CLIN ONCOL"},{"key":"2","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/bjc.2013.795","article-title":"Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes","volume":"110","author":"Lee","year":"2014","journal-title":"Br J Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2015.03.002","article-title":"Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs)","volume":"137","author":"Chen","year":"2015","journal-title":"GYNECOL ONCOL"},{"key":"4","doi-asserted-by":"publisher","first-page":"22865","DOI":"10.18632\/oncotarget.8118","article-title":"In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases","volume":"7","author":"Amir","year":"2016","journal-title":"ONCOTARGET"},{"key":"5","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/ijc.29197","article-title":"Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis","volume":"137","author":"Gayther","year":"2015","journal-title":"INT J CANCER"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Integrated genomic analyses of ovarian carcinoma. NATURE. 2011; 474:609\u2013615.","DOI":"10.1038\/nature10166"},{"key":"7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis","volume":"130","author":"Bristow","year":"2013","journal-title":"GYNECOL ONCOL"},{"key":"8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2014.03.564","article-title":"MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer","volume":"133","author":"Matei","year":"2014","journal-title":"GYNECOL ONCOL"},{"key":"9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ygyno.2014.03.563","article-title":"Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma","volume":"133","author":"Sood","year":"2014","journal-title":"GYNECOL ONCOL"},{"key":"10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7150\/jca.11242","article-title":"Prognostic significance of lymphovascular space invasion in epithelial ovarian cancer","volume":"6","author":"Pan","year":"2015","journal-title":"J CANCER"},{"key":"11","first-page":"1531","article-title":"Sprouty 1 predicts prognosis in human epithelial ovarian cancer","volume":"5","author":"Morris","year":"2015","journal-title":"AM J CANCER RES"},{"key":"12","article-title":"Overexpression of SIRT1 is Associated With Poor Outcomes in Patients With Ovarian Carcinoma","author":"Shiozawa","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"13","first-page":"429","article-title":"c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma","volume":"44","author":"Andelinovic","year":"2003","journal-title":"CROAT MED J"},{"key":"14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.pgp.0000139711.22158.14","article-title":"Loss of beta-catenin is associated with poor survival in ovarian carcinomas","volume":"23","author":"Lopes","year":"2004","journal-title":"INT J GYNECOL PATHOL"},{"key":"15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ar.20845","article-title":"Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma","volume":"292","author":"Ma","year":"2009","journal-title":"Anat Rec (Hoboken)"},{"key":"16","doi-asserted-by":"crossref","first-page":"e61565","DOI":"10.1371\/journal.pone.0061565","article-title":"HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer","volume":"8","author":"Soh","year":"2013","journal-title":"PLOS ONE"},{"key":"17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0000000000000240","article-title":"Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer","volume":"123","author":"Sood","year":"2014","journal-title":"OBSTET GYNECOL"},{"key":"18","article-title":"CD44 Immunoexpression is Unfavorable Predictor in Ovarian Serous Cancer","author":"Tomic","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ygyno.2016.01.002","article-title":"Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer","volume":"140","author":"Wright","year":"2016","journal-title":"GYNECOL ONCOL"},{"key":"20","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1093\/annonc\/mdt400","article-title":"Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer","volume":"24","author":"Smit","year":"2013","journal-title":"ANN ONCOL"},{"key":"21","doi-asserted-by":"publisher","first-page":"21054","DOI":"10.18632\/oncotarget.8245","article-title":"Development and validation of a surgical-pathologic staging and scoring system for cervical cancer","volume":"7","author":"Wu","year":"2016","journal-title":"ONCOTARGET"},{"key":"22","article-title":"Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer","author":"Mingyan","year":"2016","journal-title":"REPROD SCI"},{"key":"23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccr.2012.12.020","article-title":"Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer","volume":"23","author":"Broaddus","year":"2013","journal-title":"CANCER CELL"},{"key":"24","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/me.2007-0512","article-title":"Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha","volume":"22","author":"Leung","year":"2008","journal-title":"MOL ENDOCRINOL"},{"key":"25","article-title":"ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance","author":"Kasimir-Bauer","year":"2014","journal-title":"CLIN CHEM"},{"key":"26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.molonc.2016.04.002","article-title":"Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel","volume":"10","author":"Neubauer","year":"2016","journal-title":"MOL ONCOL"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T16:12:24Z","timestamp":1589127144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,25]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2,7]]}},"alternative-id":["14192","28039463"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14192","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,25]]}}}